Dupont Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-33,192
| Closed | -$6.1M | – | 2041 |
|
|
2021
Q2 | $6.1M | Buy |
33,192
+4,330
| +15% | +$796K | 0.14% | 111 |
|
|
2021
Q1 | $4.41M | Buy |
28,862
+7,177
| +33% | +$1.1M | 0.11% | 148 |
|
|
2020
Q4 | $3.39M | Buy |
21,685
+9,912
| +84% | +$1.55M | 0.07% | 221 |
|
|
2020
Q3 | $1.35M | Sell |
11,773
-6,344
| -35% | -$726K | 0.03% | 405 |
|
|
2020
Q2 | $2.03M | Sell |
18,117
-1,736
| -9% | -$195K | 0.04% | 307 |
|
|
2020
Q1 | $1.78M | Sell |
19,853
-5,130
| -21% | -$461K | 0.04% | 319 |
|
|
2019
Q4 | $2.7M | Buy |
24,983
+10,813
| +76% | +$1.17M | 0.06% | 281 |
|
|
2019
Q3 | $1.39M | Sell |
14,170
-1,274
| -8% | -$125K | 0.03% | 433 |
|
|
2019
Q2 | $2.02M | Buy |
15,444
+1,489
| +11% | +$195K | 0.05% | 369 |
|
|
2019
Q1 | $1.89M | Sell |
13,955
-3,463
| -20% | -$468K | 0.04% | 385 |
|
|
2018
Q4 | $1.7M | Buy |
+17,418
| New | +$1.7M | 0.04% | 392 |
|
|
2018
Q2 | – | Sell |
-1,973
| Closed | -$220K | – | 1057 |
|
|
2018
Q1 | $220K | Buy |
+1,973
| New | +$220K | 0.01% | 803 |
|
|
2017
Q4 | – | Sell |
-1,111
| Closed | -$156K | – | 1015 |
|
|
2017
Q3 | $156K | Buy |
+1,111
| New | +$156K | ﹤0.01% | 826 |
|
|
2015
Q3 | – | Sell |
-1,150
| Closed | -$208K | – | 646 |
|
|
2015
Q2 | $208K | Buy |
+1,150
| New | +$208K | ﹤0.01% | 549 |
|
|
2014
Q4 | – | Sell |
-11,900
| Closed | -$1.97M | – | 660 |
|
|
2014
Q3 | $1.97M | Sell |
11,900
-16,959
| -59% | -$2.81M | 0.03% | 331 |
|
|
2014
Q2 | $4.51M | Buy |
28,859
+5,832
| +25% | +$911K | 0.07% | 217 |
|
|
2014
Q1 | $3.5M | Buy |
+23,027
| New | +$3.5M | 0.06% | 262 |
|